Cefsulodin Sodium is a third-generation cephalosporin antibiotic. The compound has been optimized via industrial HPLC to remove significant quantities of 7-aminocephalosporanic acid (7-ACA), a key impurity in Cefsulodin synthesis that can cause instability. The result is a product with improved purity, potency, and stability.
Cefsulodin is also used in Coronavirus (SARS-CoV-2) research. In silico screening of 2421 approved small molecules and molecular dynamics simulations at Coventry University has revealed that Cefsulodin can bind to the SARS-CoV-2 S glycoprotein receptor binding domain (RBD).